Alpine Bank Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.66M Buy
1,388
+37
+3% +$37.8K 0.21% 69
2026
Q1
$1.24M Sell
1,351
-15
-1% -$15.2K 0.18% 72
2025
Q4
$1.47M Buy
1,366
+278
+26% +$266K 0.21% 64
2025
Q3
$830K Sell
1,088
-51
-4% -$38K 0.12% 87
2025
Q2
$888K Buy
1,139
+46
+4% +$35.7K 0.13% 80
2025
Q1
$903K Buy
+1,093
New +$909K 0.14% 73
2024
Q3
$2.4M Buy
+2,712
New +$2.44M 0.38% 38

Other funds holding LLY

Alpine Bank Wealth Management's LLY Position: Q2 2026 in Review

Alpine Bank Wealth Management increased its Eli Lilly (LLY) stake by 2.7% in Q2 2026, buying an estimated $37.8K and bringing the position to 1,388 shares worth $1.66M. The position accounts for 0.21% of the portfolio, ranked #69.

Alpine Bank Wealth Management first reported a position in LLY in Q3 2024 and has held it in 7 quarters since. The position peaked at $2.4M in Q3 2024. 4,637 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Alpine Bank Wealth Management held 1,388 shares of Eli Lilly worth $1.66M as of Q2 2026.
  • Alpine Bank Wealth Management bought 37 Eli Lilly shares in Q2 2026, an estimated $37.8K.
  • Eli Lilly made up 0.21% of Alpine Bank Wealth Management's portfolio in Q2 2026, its #69 holding.
  • Alpine Bank Wealth Management first reported a position in Eli Lilly in Q3 2024 and has held it in 7 quarters since.
  • Alpine Bank Wealth Management's Eli Lilly position peaked at $2.4M in Q3 2024.
  • 4,637 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Alpine Bank Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.